Delivery Order SPE2DB22D1106-SPE2DB25FEMS1

Award Date 5/8/25
Potential Completion Date 5/9/25
Potential Value $2.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4,565,550 units of the medication Eliquis 5 mg tablets. The fixed-price contract has a ceiling value of $1,928.58 and a period of performance through August 23, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a wide range of...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,567,967,952 units of the medication Eliquis 5 mg tablets. The contract has a ceiling value of $1,443.70 and a period of performance through April 21, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corp with the DLA Troop Support Medical, which...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $7,232.56, is for the delivery of 4,568,141,614 units of Eliquis 5 mg tablets. The contract has a period of performance through May 6, 2025. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support...
This is a firm-fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4,565,321,489 units of Eliquis 5 mg tablets in 60-count packs. The total ceiling value of the order is $9,977.30, with an ultimate completion date of August 2, 2024. The contract does not have a set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp. The order is for 4,565,803,432 units of Eliquis 5 mg tablets, a pharmaceutical product used to treat cardiovascular conditions. The contract has a ceiling value of $13,158.53 and an ultimate completion date of September 16, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) under an Indefinite Delivery Contract (IDC) valued at $999,999,999.00. The delivery order is for 4,567,986,163 units of Eliquis 5 mg tablets, a prescription medication, at a ceiling value of $18,353.67. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 22, 2025. This delivery order is part of a larger IDC that...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $28,631.62 and an ultimate completion date of April 21, 2025. It is for the delivery of 4,567,968,731 units of the prescription medication Eliquis 5 mg tablet in 60-count packages. The contract is not set aside and is an open competition. Amerisourcebergen Drug...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The order is for 4,565,698,951 tablets of Eliquis 2.5 mg, a prescription blood thinner medication. The contract has a firm fixed price of $3,800.16 and a completion date of September 6, 2024. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999, for providing...
This $15,256.94 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,366,817 units of the prescription drug Eliquis 5 mg tablet. The award has an ultimate completion date of August 7, 2024 and was not set aside for a specific business type. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide 4,565,735,786 tablets of the medication Eliquis 5 mg. The contract is a firm fixed-price delivery order with a ceiling value of $14,568.05 and an ultimate completion date of September 10, 2024. The contract does not have a set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB25FEMS1
    Delivery Order

This is a delivery order under a Defense Logistics Agency (DLA) contract awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for 4,568,190,466 units of the medication Eliquis 5 mg tablet 60s, with a firm fixed price ceiling value of $2,912.40. The contract has an ultimate completion date of May 9, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order is not set aside and is open to full and open competition. The contract supports the DLA's role in providing medical supplies and pharmaceuticals to military and other government healthcare programs.

Generated 8/10/25, 12:47 AM